LiveWell Announces Stock Option Grants
OTTAWA, ONTARIO, March 11, 2019, – LiveWell Canada Inc. (“LiveWell” or the “Company“),
(CSE: LVWL), today announced that it has granted an aggregate of 9,350,000 options to
purchase common stock to certain officers, employees and consultants. The options are
exercisable at a price of $0.74 per share and will vest one third on each December 31st starting
with December 31, 2019. These options will expire in five years. All options were granted in
accordance with LiveWell’s stock option plan as approved by the shareholders in December
LiveWell is an innovative Canadian health and wellness company focused on the advanced
research of CBD and other cannabinoids. Utilizing state-of-the-art manufacturing facilities,
LiveWell aims to cost-effectively extract and refine large quantities of hemp-derived CBD,
better enabling it to develop, market and distribute wholesale and consumer products.
Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts
responsibility for the adequacy or accuracy of this release.
SOURCE LiveWell Canada Inc.
For more information, visit livewellcorp.com
English – Deborah Stokes, 819 576-3789 – email@example.com
French – Conrad Seguin – firstname.lastname@example.org
Conrad Seguin, 437-226-7002 – email@example.com
David Rendimonti, President and CEO
Steven Archambault, CFO and CAO